source
- European pharma CEOs warn of biotech decline as R&D share drops to 31% and call for faster trials and stronger IP protectionNine leading European pharma board chairs issued an open letter warning that Europe is losing its biotech edge. They note that Europe's share of global pharma R&D fell from 43% in 1990 to 31% toda…
- Boston biotech seed funding drops 40% as investors favor later-stage firmsBoston remains the world’s largest biotech hub, but early‑stage startups are feeling a sharp squeeze in capital. The average seed round for a pre‑clinical company in Massachusetts fell to $4.65 mi…